These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2950716)

  • 1. The binding sites of the calcium antagonist [3H] PN 200,110 in the human myometrium and myosalpinx.
    Kleinstein J; Betjemann P; Weidacher A
    Acta Obstet Gynecol Scand; 1986; 65(8):819-22. PubMed ID: 2950716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel antagonist binding and pharmacology in rat uterine smooth muscle.
    Grover AK; Oakes PJ
    Life Sci; 1985 Dec; 37(23):2187-92. PubMed ID: 2933568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of binding of the dihydropyridine calcium antagonist PN200-110 to human myometrial sarcolemma by the heterologous calcium antagonist diltiazem.
    Golichowski AM; Tzeng DY
    Biochem Pharmacol; 1987 Apr; 36(7):1003-9. PubMed ID: 2952124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of specific bindings of nitrendipine and PN200-110 to various crude membranes: induction of irreversible bindings by UV irradiation.
    Ichida S; Fujisue T; Masada A; Oda Y; Matsuda N; Aonuma S
    J Biochem; 1989 May; 105(5):760-6. PubMed ID: 2526807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.
    Latifpour J; Yoshida M; Weiss RM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):679-87. PubMed ID: 1386146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
    Navarro J
    J Neurochem; 1986 Apr; 46(4):1166-9. PubMed ID: 3005507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.
    Bevilacqua M; Vago T; Norbiato G
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
    Pauwels PJ; Van Assouw HP; Leysen JE
    Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in calcium antagonist receptors in rabbit ureter.
    Yoshida M; Latifpour J; Weiss RM
    Dev Pharmacol Ther; 1992; 18(1-2):100-7. PubMed ID: 1483355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.